1-1 of 1
Kennedy B. Daniel, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Interim Report of the UKCLL02 Trial: A Phase II Study of Subcutaneous Alemtuzumab Plus Fludarabine in Patients with Fludarabine Refractory CLL (on Behalf of the NCRI CLL Trials Sub-Group).

Hazem Sayala, MD, Paul Moreton, MD, Jones A. Richard, PhD, Rawstron C. Andy, PhD, O’Connor Sheila, PhD, Evans Paul, PhD, Carter Anthony, MSc, Dearden Claire, MD, Matutes Estella, MD, PhD, Pettitt R. Andrew, MD, PhD, Kennedy B. Daniel, MD, Hillmen Peter, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 2120.
https://doi.org/10.1182/blood.V106.11.2120.2120
Published: 2005